Immune clues may reveal who benefits from breast cancer chemo
NCT ID NCT07407244
First seen Feb 12, 2026 · Last updated May 24, 2026 · Updated 14 times
Summary
This study is looking at 268 women with early breast cancer to see if certain immune-related factors in the tumor and blood can predict whether chemotherapy before surgery will be successful. Researchers will analyze tumor tissue and blood samples taken before treatment and check for a complete response (no cancer left after chemo). The goal is to better identify which patients are most likely to benefit from this approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.